Global Health: Epilepsy.

Area of Science:

• Neurology
• Clinical Neuroscience
• Epileptology

Background:

• Epilepsy is a misunderstood and stigmatized neurological disorder with significant global treatment disparities.
• Effective epilepsy management relies on accurate classification for prognosis and tailored treatment strategies.
• Existing treatment gaps are most pronounced in low-resource regions, highlighting the need for accessible diagnostic tools.

Purpose of the Study:

• To outline the importance of the International League Against Epilepsy's new classification system for epilepsy.
• To emphasize the critical role of diagnostic tools in accurate epilepsy diagnosis and management.
• To discuss factors influencing antiepileptic drug selection and the impact of comorbidities.

Main Methods:

• Utilizing the International League Against Epilepsy's classification system focusing on clinical aspects.
• Employing a careful patient history, clinical examination, electroencephalography (EEG), and neuroimaging.
• Reviewing pharmacological treatment, surgical candidacy, and factors influencing antiepileptic drug (AED) choice.

Main Results:

• Accurate classification guides optimal treatment and prognosis, preventing misdiagnosis and mismanagement.
• Approximately 20-30% of epilepsy patients are refractory to medications, becoming candidates for epilepsy surgery.
• AED selection is influenced by epilepsy type, patient demographics, comorbidities, drug interactions, cost, and specific patient populations (e.g., women, elderly).

Conclusions:

• The new epilepsy classification system aids in distinguishing focal from generalized epilepsy.
• Comprehensive evaluation is essential for appropriate epilepsy diagnosis and treatment.
• Collaborative efforts are vital to bridge resource gaps and improve epilepsy care globally.